Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2003 2
2004 2
2005 4
2006 1
2007 1
2008 1
2009 1
2011 5
2012 4
2013 6
2014 6
2015 7
2016 12
2017 8
2018 10
2019 10
2020 31
2021 26
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Results by year
Filters applied: . Clear all
Page 1
Probiotics and prebiotics in ulcerative colitis.
Derikx LA, Dieleman LA, Hoentjen F. Derikx LA, et al. Among authors: hoentjen f. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):55-71. doi: 10.1016/j.bpg.2016.02.005. Epub 2016 Feb 9. Best Pract Res Clin Gastroenterol. 2016. PMID: 27048897 Review.
Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
Löwenberg M, Vermeire S, Mostafavi N, Hoentjen F, Franchimont D, Bossuyt P, Hindryckx P, Rispens T, de Vries A, van der Woude CJ, Berends S, Ambarus CA, Mathot R, Clasquin E, Baert F, D'Haens G. Löwenberg M, et al. Among authors: hoentjen f. Gastroenterology. 2019 Oct;157(4):997-1006.e6. doi: 10.1053/j.gastro.2019.05.067. Epub 2019 Jun 5. Gastroenterology. 2019. PMID: 31175865
Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.
Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Löwenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F. Biemans VBC, et al. Among authors: hoentjen f. J Crohns Colitis. 2020 Jan 1;14(1):33-45. doi: 10.1093/ecco-jcc/jjz119. J Crohns Colitis. 2020. PMID: 31219157 Free PMC article.
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment.
Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, Löwenberg M, de Boer NK, Oldenburg B, Srivastava N, Jansen JM, Bodelier AGL, West RL, de Vries AC, Haans JJL, de Jong D, Hoentjen F, Pierik MJ; Dutch Initiative on Crohn and Colitis (ICC). Biemans VBC, et al. Among authors: hoentjen f. Aliment Pharmacol Ther. 2020 Jul;52(1):123-134. doi: 10.1111/apt.15745. Epub 2020 May 22. Aliment Pharmacol Ther. 2020. PMID: 32441396 Free PMC article.
Noninferiority or Nonsuperiority?
Groen MT, den Broeder N, Hoentjen F. Groen MT, et al. Among authors: hoentjen f. Gastroenterology. 2020 Dec;159(6):2248. doi: 10.1053/j.gastro.2020.02.070. Epub 2020 May 17. Gastroenterology. 2020. PMID: 32433982 No abstract available.
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
Westdorp H, Sweep MWD, Gorris MAJ, Hoentjen F, Boers-Sonderen MJ, van der Post RS, van den Heuvel MM, Piet B, Boleij A, Bloemendal HJ, de Vries IJM. Westdorp H, et al. Among authors: hoentjen f. Front Immunol. 2021 Oct 29;12:768957. doi: 10.3389/fimmu.2021.768957. eCollection 2021. Front Immunol. 2021. PMID: 34777387 Free PMC article. Review.
Golimumab for the treatment of ulcerative colitis.
Löwenberg M, de Boer NKh, Hoentjen F. Löwenberg M, et al. Among authors: hoentjen f. Clin Exp Gastroenterol. 2014 Mar 12;7:53-9. doi: 10.2147/CEG.S48741. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 24648749 Free PMC article. Review.
[Ileo-anal pouch for inflammatory intestinal disease].
Derikx LA, Heikens JT, van Laarhoven CJ, Hoentjen F. Derikx LA, et al. Among authors: hoentjen f. Ned Tijdschr Geneeskd. 2013;157(39):A5553. Ned Tijdschr Geneeskd. 2013. PMID: 24063669 Review. Dutch.
135 results